Latest Articles
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today
Published: Dec. 18, 2024, 8:16 p.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:27 p.m.
WellTheory Launches Program Targeting Link Between Autoimmune Disease and Hormonal Health - Femtech Insider
WellTheory Launches Program Targeting Link Between Autoimmune Disease and Hormonal Health Femtech Insider
Published: Dec. 18, 2024, 1:03 p.m.
Medical misogyny: fully funded, democratically-controlled NHS needed - Socialist Party
Medical misogyny: fully funded, democratically-controlled NHS needed Socialist Party
Published: Dec. 18, 2024, 12:43 p.m.
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use PMLiVE
Published: Dec. 18, 2024, 12:25 p.m.
Lib Dems call for road safety improvements in Okehampton - East Cornwall Times
Lib Dems call for road safety improvements in Okehampton East Cornwall Times
Published: Dec. 18, 2024, 7:05 a.m.
Lib Dems call for road safety improvements in Okehampton - Tavistock Times
Lib Dems call for road safety improvements in Okehampton Tavistock Times
Published: Dec. 18, 2024, 7:05 a.m.
More than 1,500 women in BCP diagnosed with endometriosis - Bournemouth Echo
More than 1,500 women in BCP diagnosed with endometriosis Bournemouth Echo
Published: Dec. 18, 2024, 5 a.m.
MP attacks Royal Mail management after controversial takeover approved - The Cornish Times
MP attacks Royal Mail management after controversial takeover approved The Cornish Times
Published: Dec. 17, 2024, 4:01 p.m.
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission - MSN
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission MSN
Published: Dec. 17, 2024, 1:27 p.m.
Link copied to clipboard!